(Q34499602)

2 August 2017

1 reference

31 October 2020

The AURORA initiative for metastatic breast cancer (English)

1 reference

early detection of cancer

2 August 2017

1 reference

31 October 2020

1 reference

18 December 2019

1 reference

31 October 2020

L Norton

21

0 references

Michael Gnant

object named as

M Gnant

19

0 references

Josep Baselga

18

object named as

J Baselga

1 reference

2 August 2017

1

D Zardavas

1 reference

2 August 2017

M Maetens

2

1 reference

2 August 2017

A Irrthum

3

1 reference

2 August 2017

T Goulioti

4

1 reference

2 August 2017

K Engelen

5

1 reference

2 August 2017

D Fumagalli

6

1 reference

2 August 2017

R Salgado

7

1 reference

2 August 2017

P Aftimos

8

1 reference

2 August 2017

K S Saini

9

1 reference

2 August 2017

C Sotiriou

10

1 reference

2 August 2017

P Campbell

11

1 reference

2 August 2017

P Dinh

12

1 reference

2 August 2017

G von Minckwitz

13

1 reference

2 August 2017

R D Gelber

14

1 reference

2 August 2017

M Dowsett

15

1 reference

2 August 2017

A Di Leo

16

1 reference

2 August 2017

D Cameron

17

1 reference

2 August 2017

A Goldhirsch

20

1 reference

2 August 2017

M Piccart

22

1 reference

2 August 2017

language of work or name

English

0 references

publication date

16 September 2014

1 reference

British Journal of Cancer

2 August 2017

11 November 2014

5 references

13 March 2019

3 April 2019

17 June 2019

18 December 2019

31 October 2020

6 references

2 August 2017

13 March 2019

3 April 2019

17 June 2019

18 December 2019

31 October 2020

111

1 reference

2 August 2017

issue

10

1 reference

2 August 2017

page(s)

1881-1887

1 reference

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

2 August 2017

copyright license

5 references

13 March 2019

3 April 2019

17 June 2019

18 December 2019

on focus list of Wikimedia project

31 October 2020

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

Personalized therapy for breast cancer: a dream or a reality?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

Designing transformative clinical trials in the cancer genome era.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

Emerging targeted agents in metastatic breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

Genome sequencing identifies a basis for everolimus sensitivity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

Sequence analysis of mutations and translocations across breast cancer subtypes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

The landscape of cancer genes and mutational processes in breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

Whole-genome analysis informs breast cancer response to aromatase inhibition

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

The clonal and mutational evolution spectrum of primary triple-negative breast cancers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

Systematic identification of genomic markers of drug sensitivity in cancer cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

PI3K pathway mutations and PTEN levels in primary and metastatic breast cancer.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

Tumour evolution inferred by single-cell sequencing

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

PIK3CA Mutations May Be Discordant between Primary and Corresponding Metastatic Disease in Breast Cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

Genome remodelling in a basal-like breast cancer metastasis and xenograft

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

Evaluation of HER2, p53, bcl-2, topoisomerase II-alpha, heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodes.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229627

Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER).

7 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.341

PIK3CA mutations rarely demonstrate genotypic intratumoral heterogeneity and are selected for in breast cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.341

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.341

Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.341

Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25225904

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.2014.341

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference